Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mytrex Health TechnologiesROCO:4431 +2.06%64 PB Ratio is 1.08 as of Jul. 19, 2026, which is 17% below its 10-year median of 1.30. GuruFocus rates ROCO:4431 with a GF Score™ of 64/100 and a GF Value™ of NT$37.17 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 2,982 Industrial Products companies, Mytrex Health Technologies ranks better than 76.96% on this metric.
Mytrex Health Technologies Inc stock PB Ratio (=1.08) is close to 2-year low of 1.
The historical rank and industry rank for Mytrex Health Technologies's PB Ratio or its related term are showing as below:
ROCO:4431'
s PB Ratio Range Over the Past 10 Years
Min: 0.61 Med: 1.3 Max: 12.61
Current: 1.08
During the past 13 years, Mytrex Health Technologies's highest PB Ratio was 12.61. The lowest was 0.61. And the median was 1.30.
ROCO:4431's PB Ratio is ranked better than 76.96% of 2982
companies
in the Industrial Products industry
Industry Median: 2.14
vs ROCO:4431: 1.08
During the past 12 months, Mytrex Health Technologies's average Book Value Per Share Growth Rate was -2.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -15.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -10.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Mytrex Health Technologies was 39.90% per year. The lowest was -15.40% per year. And the median was 5.95% per year.
Back to Basics: PB Ratio
Mytrex Health Technologies (ROCO:4431) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Mytrex Health Technologies PB Ratio Related Terms
Mytrex Health Technologies PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mytrex Health Technologies PB Ratio vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's PB Ratio distribution charts can be found below:
* The bar in red indicates where Mytrex Health Technologies's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Mytrex Health Technologies (ROCO:4431) has a PB Ratio of 1.08 as of Jul. 19, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mytrex Health Technologies and its competitors. This is 17% below median its historical median of 1.30. Over the past decade, Mytrex Health Technologies' PB Ratio has ranged from 0.61 to 12.61. According to the industry distribution chart, Mytrex Health Technologies ranks #687 out of 2982 companies in the Industrial Products industry, placing it in the top 23%.
Is Mytrex Health Technologies' PB Ratio too high?
Mytrex Health Technologies' current PB Ratio of 1.08 is 17% below median its 10-year median of 1.30. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 12.61. The Industrial Products industry median PB Ratio is 2.14. Mytrex Health Technologies' value of 1.08 is 49.5% below this industry median. Based on the distribution chart, Mytrex Health Technologies ranks #687 out of 2982 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Mytrex Health Technologies has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mytrex Health Technologies' PB Ratio compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Mytrex Health Technologies ranks #687 out of 2982 companies for PB Ratio. This places Mytrex Health Technologies in the top 23% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.14. Mytrex Health Technologies' value of 1.08 is 49.5% below this benchmark. Historically, Mytrex Health Technologies' own PB Ratio has ranged from 0.61 to 12.61 over the past decade. While the company's 10-year median is 1.30 vs. the industry median of 2.14, Mytrex Health Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Industrial Products company?
The median PB Ratio among Industrial Products companies is 2.14, based on 2,982 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mytrex Health Technologies's current PB Ratio of 1.08 is 49.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Mytrex Health Technologies and its competitors. For the Industrial Products industry, the median PB Ratio is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mytrex Health Technologies's current PB Ratio is 1.08, which is 17% below median its own 10-year median of 1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mytrex Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, Mytrex Health Technologies (ROCO:4431) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$37.17, compared to a current price of NT$17.35 — trading 53.3% below its estimated fair value. The current PB Ratio is 1.08, which is 17% below median its 10-year median of 1.30 and 49.5% below the Industrial Products industry median of 2.14. Mytrex Health Technologies' overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Mytrex Health Technologies (ROCO:4431), the current PB Ratio is 1.08 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?
Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued.
The current stock price of NT$17.35 is trading 53.3% below its estimated GF Value™ of NT$37.17.
GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.
Key valuation signals for ROCO:4431:
PB Ratio: 1.08 (17% below median its 10-year median of 1.30)
GF Value™: NT$37.17 vs. price of NT$17.35 (53.3% below fair value)
Industry Position: 49.5% below the Industrial Products median (#687 of 2982)
No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
64GF Score
Get the complete analysis for ROCO:4431
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4431 has been successfully added to your 
